Mental health care company focused on accelerating patient access to evidence based innovation in medical health Compass Pathways PLC. (CMPS) announced having appointed Professor Guy Goodwin as the new chief medical officer of the London based company.
Professor Goodwin has a remarkable experience across the wide medical field. He has previously served as the head of the University of Oxford’s Department of Psychiatry. He has also been the president of the British Association for Psychopharmacology.
Currently, Prof Goodwin is serving as the medical director at Pivotal, a clinical research company aiming to make CNS treatment development more efficient via the use of innovative technologies like digital solutions and biomarkers.
“I have been working with COMPASS in an advisory capacity since the beginning of the phase 2b clinical trial of psilocybin therapy for treatment-resistant depression. I am now delighted to be taking a more active role in bringing this innovative therapy to patients who desperately need new options in psychiatry,” said Prof Goodwin.
